ATNM
$1.14
Actinium Pharmaceuticals, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company advances two clinical stage product candidates, A...
Recent News
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?
Here is how Actinium Pharmaceuticals (ATNM) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.
Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?
Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.
Actinium: Q3 Earnings Snapshot
NEW YORK (AP) — Actinium Pharmaceuticals Inc. ATNM) on Friday reported a loss of $5.1 million in its third quarter. On a per-share basis, the New York-based company said it had a loss of 16 cents.
Sector Update: Health Care Stocks Advance Monday Afternoon
Health care stocks rose Monday afternoon, with the NYSE Health Care Index and the Health Care Select